Goldman Sachs Group Inc Green Light Biosciences Holdings, Pbc Transaction History

Goldman Sachs Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 14, 2024	BUY	$0.18 - $0.48 $15,920 - $42,454	88,446 Added 142.35%	150,579 $45,000
Q2 2023 Aug 14, 2023	BUY	$0.18 - $0.48 $15,920 - $42,454	88,446 Added 142.35%	150,579 $45,000
Q1 2023 May 14, 2024	SELL	$0.34 - $1.19 $5,081 - $17,784	-14,945 Reduced 19.39%	62,133 $26,000
Q1 2023 May 11, 2023	SELL	$0.34 - $1.19 $5,081 - $17,784	-14,945 Reduced 19.39%	62,133 $26,000
Q4 2022 May 14, 2024	BUY	$1.03 - $2.0 $49,435 - $95,992	47,996 Added 165.04%	77,078 $90,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.0 $49,435 - $95,992	47,996 Added 165.04%	77,078 $90,000
Q3 2022 May 14, 2024	BUY	$0.42 - $3.92 $12,214 - $114,001	29,082 New	29,082 $67,000
Q3 2022 Nov 10, 2022	BUY	$0.42 - $3.92 $12,214 - $114,001	29,082 New	29,082 $0
Q2 2022 Aug 15, 2022	SELL	N/A	-26,807 Closed	0 $0
Q1 2022 May 16, 2022	BUY	N/A	26,807 New	26,807 $258,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.